fda cobenfy news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

FOX News on MSN · 10h

New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.

Reason · 6h

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

WXYZ3h

FDA approves first new medication to treat schizophrenia in more than 30 years

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

C&EN1d

FDA approves Cobenfy, a first-in-class schizophrenia drug

But Cobenfy can still cause side effects, the most common of which are gastrointestinal in nature like nausea and vomiting, diarrhea, indigestion, and constipation. The FDA says people with known ...

15h

Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)

Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...

BioWorld9h

US FDA clears Cobenfy, first new schizophrenia drug in decades

The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results